PUBLISHER: The Business Research Company | PRODUCT CODE: 1672330
PUBLISHER: The Business Research Company | PRODUCT CODE: 1672330
Breast imaging devices are medical equipment crucial for screening, diagnosing, and supporting breast health, including cancerous and noncancerous breast diseases. These devices play a vital role in early detection and treatment of breast cancer.
Key product types in breast imaging devices include tomosynthesis, breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Tomosynthesis is an imaging method employed for both screening and diagnostic purposes, particularly in individuals with or without symptoms of breast cancer. Breast imaging devices utilize ionizing and non-ionizing technologies. These devices find application in hospitals, clinics, breast care centers, and diagnostic imaging centers.
The breast imaging devices market research report is one of a series of new reports from The Business Research Company that provides breast imaging devices market statistics, including breast imaging devices industry global market size, regional shares, competitors with a breast imaging devices market share, detailed breast imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the breast imaging devices industry. This breast imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The breast imaging devices market size has grown strongly in recent years. It will grow from $4.88 billion in 2024 to $5.14 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to growth in the number of healthcare facilities, economic growth in emerging markets, rapid technological advances, the rising prevalence of breast cancer, and aging female population.
The breast imaging devices market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to awareness for early detection of breast diseases, rising use of diagnostic medical imaging, and increasing investment and funding for breast cancer treatments. Major trends in the forecast period include investing in product portfolio expansion, strategic collaboration, and increasing investment in the development of portable devices, investing in photoacoustic breast imaging, augmented reality (AR) for breast imaging, and hybrid imaging technology.
The expansion of the breast imaging device market is attributed to the escalating prevalence of breast cancer. Factors such as increased exposure to hormone replacement therapies (HRT), hormonal imbalances, menopause, and several reproductive disorders have significantly elevated the risk of breast cancer among individuals. Breast cancer stands as the most prevalent cancer affecting women globally, as per statistics from the World Health Organization (WHO), impacting approximately 2.1 million women annually. Additionally, it leads to the highest number of cancer-related fatalities among women. A recent report from the American Society of Clinical Oncology (ASCO) indicated that 1 in 3 new female cancer cases in the United States is diagnosed as breast cancer. In the year 2023, an estimated 297,790 women in the United States are expected to be diagnosed with invasive breast cancer and 55,720 with non-invasive (in situ) breast cancer.
The rising healthcare expenditure is anticipated to drive the growth of the breast imaging devices market in the future. Healthcare expenditure refers to the total amount of money allocated for healthcare goods and services within a specific region or country over a defined period. This spending encompasses medical consultations, hospital visits, surgeries, diagnostic tests, and treatments. It also includes costs associated with breast cancer screening, diagnosis, and treatment using breast imaging devices, as well as investments in research and development (R&D) for breast imaging technology. For example, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion), representing a nominal increase of 0.7% compared to 2021. Consequently, the rise in healthcare expenditure is driving the growth of the breast imaging devices market.
Leading companies in the breast imaging devices market are concentrating on developing technologically advanced solutions, such as cutting-edge imaging techniques, to enhance early detection and improve diagnostic accuracy for breast cancer. Advanced imaging techniques refer to sophisticated methods that provide detailed and precise visualizations of the body's internal structures, including digital mammography, 3D tomosynthesis, and magnetic resonance imaging (MRI). For example, in October 2024, StoneSprings Hospital Centre, a US-based healthcare facility, introduced new breast imaging technology. This innovative technology employs state-of-the-art imaging modalities, such as digital mammography and 3D tomosynthesis, which deliver clearer and more detailed images of breast tissue. This advancement aids in detecting abnormalities that may not be visible through traditional 2D mammography. The system is designed to incorporate artificial intelligence (AI) algorithms to assist radiologists in more accurately interpreting images. AI can help by flagging potential areas of concern, thereby minimizing the risk of missed diagnoses and enhancing overall accuracy.
Leading companies in the breast imaging devices market are placing a strong emphasis on AI-driven technology development, exemplified by products such as Imagio. Imagio, introduced by Seno Medical Instruments Inc. in November 2022 and approved by the FDA, is a breast imaging system utilizing opto-acoustic/ultrasound (OA/US) hybrid modality for real-time assessment and differentiation between malignant and benign breast tissue. Capable of detecting tumors as small as 3mm, Imagio incorporates an AI decision-support tool called SenoGram, aiding physicians in interpreting images effectively. This strategic integration of AI technology reflects a commitment to innovation and diagnostic excellence in breast cancer diagnosis.
In May 2024, Lunit, a South Korea-based medical AI company specializing in software for cancer screening and treatment, acquired Volpara Health Technologies Limited for an undisclosed amount. Through this acquisition, Lunit aims to enhance its AI-driven cancer diagnostics, expand its presence in the U.S. market, and develop innovative solutions for early cancer detection and improved patient outcomes. Volpara Health Technologies Limited is a New Zealand-based software company that enhances breast imaging devices with cutting-edge software to improve cancer detection.
Major companies operating in the breast imaging devices market include Siemens Healthineers AG, Hologic, Inc., GE Healthcare, FUJIFILM Holdings Corporation, Canon, Philips Healthcare, Aurora Imaging Technology Inc., Delphinus Medical Technologies, Micrima Limited, SonoCine Inc., Hitachi, Ltd., QT Ultrasound LLC, Trivitron Healthcare, Telerad Tech, Henan Forever Medical Co., Ltd., Guangzhou Medsinglong Medical Equipment Co., Ltd., Medsinglong Co Ltd, Toshiba Corporation, Wuhan Darppon Medical Technology Co., Ltd., Planmed Oy, Barco NV, Esaote SpA
North America was the largest region in the breast imaging devices market in 2024. Asia-Pacific was the second largest market in the global breast imaging devices market report. The regions covered in the breast imaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the breast imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The breast imaging devices market consists of sales of imaging equipment such as breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Breast Imaging Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on breast imaging devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for breast imaging devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The breast imaging devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.